Random mutagenesis of BoNT/E Hc nanobody to construct a secondary phage-display library

被引:10
作者
Shahi, B. [1 ]
Gargari, S. L. Mousavi [1 ]
Rasooli, I. [1 ,2 ]
Bazl, M. Rajabi [3 ]
Hoseinpoor, R. [1 ]
机构
[1] Shahed Univ, Dept Biol, Basic Sci Fac, Tehran 3319118651, Iran
[2] Shahed Univ, Mol Microbiol Res Ctr, Tehran 3319118651, Iran
[3] Shahid Beheshti Univ Med Sci, Dept Clin Biochem, Faculaty Med, Tehran, Iran
关键词
affinity maturation; BoNT/E; error-prone PCR; nanobody; phage-display library; AFFINITY MATURATION; MONOCLONAL-ANTIBODY; BOTULINUM TOXIN; BINDING; DOMAIN; ENHANCEMENT; EVOLUTION; PROTEIN; UNIQUE;
D O I
10.1111/jam.12526
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims: To construct secondary mutant phage-display library of recombinant single variable domain (VHH) against botulinum neurotoxin E by error-prone PCR. Methods and Results: The gene coding for specific VHH derived from the camel immunized with binding domain of botulinum neurotoxin E (BoNT/E) was amplified by error-prone PCR. Several biopanning rounds were used to screen the phage-displaying BoNT/E Hc nanobodies. The final nanobody, SHMR4, with increased affinity recognized BoNT/E toxin with no cross-reactivity with other antigens especially with related BoNT toxins. Conclusions: The constructed nanobody could be a suitable candidate for VHH-based biosensor production to detect the Clostridium botulinum type E. Significance and Impact of the Study: Diagnosis and treatment of botulinum neurotoxins are important. Generation of high-affinity antibodies based on the construction of secondary libraries using affinity maturation step leads to the development of reagents for precise diagnosis and therapy.
引用
收藏
页码:528 / 536
页数:9
相关论文
共 40 条
[1]  
Alirezapour Behruz, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P172, DOI 10.1089/mab.2012.0093
[2]  
[Anonymous], 2010, Drug Discov Today Technol, V7, pe95, DOI 10.1016/j.ddtec.2010.03.002
[3]   Altering protein specificity: techniques and applications [J].
Antikainen, NM ;
Martin, SF .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (08) :2701-2716
[4]   A novel nanobody against urease activity of Helicobacter pylori [J].
Ardekani, Leila Safaee ;
Gargari, Seyed Latif Mousavi ;
Rasooli, Iraj ;
Bazl, Masoumeh Rajabi ;
Mohammadi, Mohammad ;
Ebrahimizadeh, Walead ;
Bakherad, Hamid ;
Zare, Hamed .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (09) :E723-E728
[5]   In Vivo Neutralization of Botulinum Neurotoxins Serotype E with Heavy-chain Camelid Antibodies (VHH) [J].
Bakherad, Hamid ;
Gargari, Seyed Latif Mousavi ;
Rasooli, Iraj ;
RajabiBazl, Masoumeh ;
Mohammadi, Mohammad ;
Ebrahimizadeh, Walead ;
Ardakani, Leila Safaee ;
Zare, Hamed .
MOLECULAR BIOTECHNOLOGY, 2013, 55 (02) :159-167
[6]   MEASUREMENT OF MONOCLONAL-ANTIBODY AFFINITY BY NONCOMPETITIVE ENZYME-IMMUNOASSAY [J].
BEATTY, JD ;
BEATTY, BG ;
VLAHOS, WG .
JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 100 (1-2) :173-179
[7]   Low-fidelity Pyrococcus furiosus DNA polymerase mutants useful in error-prone PCR -: art. no. e176 [J].
Biles, BD ;
Connolly, BA .
NUCLEIC ACIDS RESEARCH, 2004, 32 (22) :e176
[8]   Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins [J].
Butler, David C. ;
McLear, Julie A. ;
Messer, Anne .
PROGRESS IN NEUROBIOLOGY, 2012, 97 (02) :190-204
[9]   Fine epitope mapping anti-epidermal growth factor receptor antibodies through random mutagenesia and yeast surface display [J].
Chao, G ;
Cochran, JR ;
Wittrup, KD .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 342 (02) :539-550
[10]   Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design [J].
Clark, LA ;
Boriack-Sjodin, PA ;
Eldredge, J ;
Fitch, C ;
Friedman, B ;
Hanf, KJM ;
Jarpe, M ;
Liparoto, SF ;
Li, Y ;
Lugovskoy, A ;
Miller, S ;
Rushe, M ;
Sherman, W ;
Simon, K ;
Van Vlijmen, H .
PROTEIN SCIENCE, 2006, 15 (05) :949-960